ONCAlert | Upfront Therapy for mRCC

Liquid Biopsies VIEW MORE >>

In an interview with Targeted Oncology, John Simmons, PhD, discussed the potential role of liquid biopsy assays in predicting response to immune checkpoint inhibitor therapy for patients with cancer. He also highlighted other liquid biopsy assays that are in development for detecting MSI.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.